Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. cut its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 5.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,077,948 shares of the company’s stock after selling 174,389 shares during the period. Principal Financial Group Inc. owned 2.56% of Privia Health Group worth $60,175,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Financial Management Professionals Inc. acquired a new stake in shares of Privia Health Group in the 4th quarter valued at about $51,000. Quarry LP raised its stake in Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after buying an additional 2,533 shares in the last quarter. KBC Group NV raised its stake in Privia Health Group by 34.6% during the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after buying an additional 871 shares in the last quarter. Neo Ivy Capital Management bought a new position in Privia Health Group during the 3rd quarter worth approximately $66,000. Finally, Values First Advisors Inc. acquired a new position in shares of Privia Health Group in the 3rd quarter worth approximately $83,000. 94.48% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

PRVA has been the topic of several research reports. Stephens reissued an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. Barclays increased their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Truist Financial lifted their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. JMP Securities reiterated a “market outperform” rating and set a $26.00 price objective on shares of Privia Health Group in a research note on Friday, February 14th. Finally, Needham & Company LLC started coverage on shares of Privia Health Group in a report on Friday, January 10th. They issued a “buy” rating and a $25.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $24.94.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA opened at $25.50 on Thursday. The company has a market capitalization of $3.06 billion, a PE ratio of 255.03, a price-to-earnings-growth ratio of 3.56 and a beta of 0.87. The stock has a fifty day moving average of $21.85 and a 200-day moving average of $20.33. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $25.67.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.